Iptd-694

The specific mechanism of action of IPTD-694 is not yet fully understood, but it is believed to involve the modulation of the glycosphingolipid (GSL) metabolism pathway. In rare genetic disorders such as Fabry disease and Gaucher disease, there is an accumulation of GSLs in various tissues due to deficiencies in specific enzymes involved in their breakdown. IPTD-694 is thought to interact with this pathway to restore normal GSL metabolism and reduce the accumulation of toxic intermediates.

Exploring the Future of [Topic]